【摘 要】
：
Methods:The records cervical cancer patients with squamous cell carcinoma(stage IB to IVA)underwent definitive radiotherapy in year 2009-2013 were retrospective studied.The patients received the total
【机 构】
：
Medical Physics Master Degree Program,Department of Radiology,Chiang Mai University,Chiang Mai,Thail
【出 处】
：
The 15th Asia-Oceania Congress of Medical Physics (AOCMP2015
论文部分内容阅读
Methods:The records cervical cancer patients with squamous cell carcinoma(stage IB to IVA)underwent definitive radiotherapy in year 2009-2013 were retrospective studied.The patients received the totally cumulative dose in EQD2 at point A ranged from 83.6 to 86.1 Gy.The total 130 patients were separated into 2 groups based on OTT recommended by ABS,OTT≤56 day(group1)and >56 day(group 2)and the relationship between the treatment outcomes was analyzed using Kaplan-meier,log-rank test,Cox regression,univariate and multivariate analysis(MVA)and Chi-square test.Results:OTT ranged 44-88 day.EQD2 ranged 83.6-86.1 Gy.The local control rate(p=0.681),disease metastasis free rate(p=0.867),Disease Free Survival(DFS)(p=0.769),cause specific survival(p=0.605)and Overall Survival(OS)(p=0.779)were not significantly different between 2 group.MVA identified tumor size(p=0.016 and p=0.014)as the prognostic factor of DFS and OS.There was no statistical significance in both acute and late complication [skin(p=0.922,N/A),subcutaneous tissue(p=0.558,p=1.000),Gastrointestinal(GI)(p=0.682,p=0.474)and Genitourinary(GU)(p=1.000,p=1.000),respectively].The cumulatively rectal dose(in EQD2)was further analyzed,<70 Gy3(group1)and ≥70 Gy3(group2),there were not significance different in acute GI and late GI complication(p=0.422 and p=0.459).Conclusion:The treatment outcome; local control,survival and complications,were not influence by OTT.Tumor size greater than 4 cm was the prognostic factor of DFS and OS.
其他文献
研究目的：分析骨骺牵张技术在儿童恶性骨肿瘤保留骨骺保肢术中的临床疗效.方法：回顾性分析国内四家医院15例恶性骨肿瘤患者(9男,6女),行保肢手术前均先行骨骺牵张手术.平均年龄10岁(6-15岁).骨肉瘤14例,尤文肉瘤1例.肿瘤位于股骨远端9例,胫骨近端6例.采用MSTS评分对患者进行功能评分.结果：平均随访22个月(4-59个月),8例(53％)术后双下肢等长.12例(86％)没有肿瘤复发或转移
Background: This study aimed to develop a prognostic index to predict the 5-year overall survival(OS)and 5-year lung metastasis-free survival(LMFS)for patients with extremity osteosarcoma at the time
目的 探讨肿瘤假体置换手术在治疗股骨远端骨肉瘤中的疗效和相关问题.方法 回顾分析2001年9月至2013年4月,106例接受瘤段骨切除、肿瘤假体重建且有完整随访的股骨远端原发性骨肉瘤患者的疗效.其中男性64例,女性42例,术时患者平均年龄23.11±7.7岁(15～44岁).Enneking外科分期11例为IIA,余95例为IIB.术后平均随访54.82±10.17个月(24～162个月).以MS
目的 股骨近端骨干组配式假体是重建节段式骨缺损的常用方法之一，虽然目前已有临床应用，但是人们对于骨缺损重建后假体的稳定性并不了解，特别是近端柄长度变化和外加侧方钢板是否会影响假体重建的稳定性尚需讨论。本文通过有限元方法探讨近端柄长度变化和外加侧方钢板辅助固定对假体稳定性的影响，为医生对股骨近端肿瘤患者临床骨干组配式假体的选择提供参考。
目的:骨肉瘤是最常见的原发性恶性骨肿瘤,肺转移发生早,预后差.转录共激活因子4(PC4)参与了DNA转录、复制、修复、染色质重塑等多个转录过程,但其具体功能尚不明确.本研究旨在探讨PC4在骨肉瘤中的具体作用.方法:对比分析人体骨肉瘤组织和正常组织;慢病毒敲减高肺转移骨肉瘤细胞株143B中PC4的表达,RNA测序分析差异表达基因,观察143B的恶性表型变化;分析和验证可能的分子调控途径.
目的:探讨肢体骨肉瘤新辅助化疗的疗效评估系统的近期临床效果.方法:回顾性分析我科2013年1月至2013年12月收治并进行新辅助化疗疗效评估的且随访资料完整的36肢体骨肉瘤患者资料.对确诊为骨肉瘤的患者先进行新辅助化疗,化疗后利用我科自行设计的新辅助化疗评估系统进行打分,根据打分结果判断新辅助化疗的效果.化疗后进行手术,采取肿瘤标本进行病理分析并计算肿瘤坏死率.
BIRC5/survivin genetic 3-untranslated regions(3UTR)microRNA(miRNA)binding sites variants are significantly associated with cancer risk,but,the roles of genetic variants in BIRC5/survivin gene 3UTR and
Objective.The aim of this study was to evaluate the relationship between glutathione S-transferase p1(GSTP1)polymorphisms and prognosis of osteosarcoma patients treated with chemotherapy by performing
目的 分析膝关节周围骨巨细胞瘤(giant cell tumor,GCT)病理性骨折的临床和影像学特征。方法 回顾2000年3月至2015年4月之间中国骨巨细胞瘤协作组(giant cell tumor team of China,GTOC)包括天津医院、济南军区总医院、西京医院、浙医二院、南京军区总医院、内蒙二院和河北省三院7家骨肿瘤治疗中心收集的153例胫骨近端和股骨远端伴病理性骨折的原发GC
目的 骨巨细胞瘤(giant cell tumors of bone,GCT)是我国最常见的原发性骨肿瘤之一。但尚缺乏来自国家代表性样本的报道。本研究目的是应用多中心国家代表性GCT数据库,探讨中国人骨巨细胞瘤的分布特征,为进一步开展GCT的临床和基础研究奠定基础。方法 所有病例选自2002年～2014年期间在11家三甲医院(中国骨巨细胞瘤协作组)就医的骨巨细胞瘤患者。选择有明确诊断的各部位GCT